Co-led by Veriq’s Co-founder and Chief Medical Officer, Professor Andy Metcalfe, the NIHR-funded RACER-Knee trial compared Mako robotic-assisted and conventional knee replacement in 339 patients across 10 NHS hospitals. It found greater surgical precision but higher costs and no clinically meaningful patient benefit at 12 months, highlighting the importance of robust clinical evidence when evaluating new surgical technologies.